Receptor, Epidermal Growth Factor

3 trials

Sponsors

Center of Molecular Immunology, Center of Molecular Immunology (CIM)

Conditions

Hormone refractory prostate cancerNon Small Cell Lung Cancerhormonal castration-resistant prostate cancer, squamous cell carcinoma of the head and neck, and advanced colon cancer

Phase 1

EC122 HER-1 Prostate Phase I

Active, not recruitingRPCEC00000219

Center of Molecular ImmunologyHormone refractory prostate cancer

Start: 2009-10-23Target: 25Updated: 2026-03-30

Vaccine HER1 / VSSP for prostate cancer, head and neck carcinoma and advanced colon cancer . Phase I

Active, not recruitingRPCEC00000258

Center of Molecular Immunology (CIM)hormonal castration-resistant prostate cancer, squamous cell carcinoma of the head and neck, and advanced colon cancer

Start: 2017-11-15Target: 120Updated: 2026-03-30

Unknown Phase

Combined NGcGM3/VSSP and Nimotuzumab in advanced non-small cell lung cancer (NSCLC)

Active, not recruitingRPCEC00000270

Center of Molecular Immunology (CIM)Non Small Cell Lung Cancer

Start: 2018-04-30Target: 30Updated: 2026-03-30